Cargando…

Regulation of cancer stem cells in triple negative breast cancer

Triple Negative Breast Cancer (TNBC) is the most lethal subtype of breast cancer. Despite the successes of emerging targeted therapies, relapse, recurrence, and therapy failure rates in TNBC significantly outpace other subtypes of breast cancer. Mounting evidence suggests accumulation of therapy res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fultang, Norman, Chakraborty, Madhuparna, Peethambaran, Bela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019272/ https://www.ncbi.nlm.nih.gov/pubmed/35582030 http://dx.doi.org/10.20517/cdr.2020.106

Ejemplares similares

Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
por: Fultang, Norman, et al.
Publicado: (2019)

ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
por: Fultang, Norman, et al.
Publicado: (2020)

Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements
por: Illendula, Abhinav, et al.
Publicado: (2020)

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
por: Park, So-Yeon, et al.
Publicado: (2019)

Identification and validation of a small molecule targeting ROR1 for the treatment of triple negative breast cancer
por: Gupta, Shradheya R. R., et al.
Publicado: (2023)

The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer
por: He, Lin, et al.
Publicado: (2021)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
por: Rangel, Maria Cristina, et al.
Publicado: (2016)

Emerging Immunotherapies against Novel Molecular Targets in Breast Cancer
por: Sivaganesh, Vignesh, et al.
Publicado: (2021)

Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
por: Mahmoud, Rinad, et al.
Publicado: (2022)

Effects of Cancer Stem Cells in Triple-Negative Breast Cancer and Brain Metastasis: Challenges and Solutions
por: Lee, Kha-Liang, et al.
Publicado: (2020)

Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
por: Yamashita, Nami, et al.
Publicado: (2022)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cells Markers in Triple-Negative Breast Cancer
por: Collina, Francesca, et al.
Publicado: (2015)

Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
por: Lee, Kha-Liang, et al.
Publicado: (2019)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Immunotherapeutic interventions of Triple Negative Breast Cancer
por: Li, Zehuan, et al.
Publicado: (2018)

Triple negative breast cancer: the kiss of death
por: Jitariu, Adriana-Andreea, et al.
Publicado: (2017)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
por: Tian, Jun, et al.
Publicado: (2017)

Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors
por: Yang, Fang, et al.
Publicado: (2016)

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells
por: Tian, Jun, et al.
Publicado: (2018)

From Interaction to Intervention: How Mesenchymal Stem Cells Affect and Target Triple-Negative Breast Cancer
por: Wu, Yong, et al.
Publicado: (2023)

THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
por: Bai, Xupeng, et al.
Publicado: (2021)

Management Options in Triple-Negative Breast Cancer
por: Minami, Christina A., et al.
Publicado: (2011)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)

Triple negative breast cancer: Pitfalls and progress
por: Zagami, Paola, et al.
Publicado: (2022)

Triple-negative breast cancer and radiation therapy
por: de Faria Bessa, Jordana, et al.
Publicado: (2022)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o1deid1s1plff52e8h01n5uurh